Prof. NAZİF ELALDI

Publication Network

Articles 156

1. Detection of Anaplasma capra in Patients with Suspected Crimean-Congo Hemorrhagic Fever, Turkey, 2022.

Altay K., Elaldi N., Erol U., Koksal B., Sahin O. F., Pektas A. N., et al.

Emerging infectious diseases , vol.32, no.10, pp.1561-1570, 2026 (SCI-Expanded, Scopus)

2. ABO Blood Groups and Clinical Outcomes in Crimean-Congo Hemorrhagic Fever: Insights From a Large Turkish Cohort.

Öksüz C., Büyüktuna S. A., Öz M., Keskin E., Çubuk F., Çakır Kıymaz Y., et al.

Journal of tropical medicine , vol.2026, pp.3461989, 2026 (SCI-Expanded, Scopus)

3. The Wells–Riley Model Revisited II: Parameter Uncertainty and Population Heterogeneity

Marshall M., Edwards A. J., Pinnell D., King M., Noakes C. J., Elaldı N., et al.

Risk Analysis , vol.46, no.8, 2026 (SCI-Expanded, SSCI, Scopus)

4. Dynamic Prognostic Value of IL-6/PLT Ratio for Mortality Discrimination in Patients With Crimean-Congo Hemorrhagic Fever: Sequential ROC Analysis Throughout the Clinical Course: IL-6/PLT Ratio for Mortality Discrimination in CCHF

Öz M., Öksüz C., Keskin E., Parlak R., Dağci E. İ., Tutku Bağ Ç., et al.

Journal of Medical Virology , vol.98, no.8, 2026 (SCI-Expanded, Scopus)

5. Evaluation of hematological and biochemical parameters in the differential diagnosis of Crimean-Congo hemorrhagic fever and brucellosis: insights from a large patient cohort.

Öksüz C., Öz M., Keskin E., Bozkurt Demircioğlu S., Aldemir Ö., Çakır Kıymaz Y., et al.

BMC infectious diseases , vol.26, no.1, 2026 (SCI-Expanded, Scopus)

6. The Impact of Admission Viral Load and Inflammatory Markers on Mortality and Prognosis in Crimean-Congo Hemorrhagic Fever.

Çakır Kıymaz Y., Keskin E., Öksüz C., Büyüktuna S. A., Elaldı N.

Journal of medical virology , vol.98, no.7, 2026 (SCI-Expanded, Scopus)

7. Multiple Reassortments, Limited Geographic Spread, and Comparable Pathogenicity of Crimean-Congo Hemorrhagic Fever Viruses in Sivas Province, Türkiye

Lin Q., Elaldı N., Yigit M., Yildiz B., Hewson R., López-García M., et al.

Journal of Medical Virology , vol.98, no.6, 2026 (SCI-Expanded, Scopus)

8. A Rare Catheter-Related Bloodstream Infection: Streptococcus dysgalactiae subsp. equisimilis

Çakır Kıymaz Y., Yeşildağ S., Hasbek M., Büyüktuna S. A., Elaldı N.

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.31, no.2, pp.223-226, 2026 (ESCI, TRDizin)

9. Prognostic Value of Admission Glucose and Extended Lipid Profile in Patients with Crimean-Congo Hemorrhagic Fever

Kıymaz Y. Ç., Baysal C., Öksüz C., Büyüktuna S. A., Elaldı N.

Journal of Medical Virology , vol.98, no.4, 2026 (SCI-Expanded, Scopus)

10. Evaluation of the relationship between signal time in blood cultures and clinical findings in brucellosis cases.

Öz M., Keskin E., Çubuk F., Öksüz C., Aldemir Ö., Topçu K. F., et al.

Diagnostic microbiology and infectious disease , vol.115, no.3, pp.117369, 2026 (SCI-Expanded, Scopus)

11. The first detection of Jingmen tick virus (JMTV) in humans in Türkiye, 2022

Öz M., Dinçer E., Pektaş A. N., Timurkan M. Ö., Bağcı B., Taşseten T. N., et al.

Pathogens and Global Health , vol.120, no.2, pp.149-156, 2026 (SCI-Expanded, Scopus)

12. The first reported Crimean–Congo hemorrhagic fever reinfection in the literature: 11 years apart

Büyüktuna S. A., Çakır Kıymaz Y., Öksüz C., Öz M., Baysal C., Elaldı N.

Diagnostic Microbiology and Infectious Disease , vol.114, no.1, 2026 (SCI-Expanded, Scopus)

13. A system to rapidly develop a bunyavirus pseudotyped virus neutralisation assay for pandemic preparedness.

Marchesin F., Bentley E. M., Mutuku F., Jeza V., Ndenga B., Kempster S., et al.

NPJ vaccines , vol.10, no.1, pp.228, 2025 (SCI-Expanded, Scopus)

14. Laboratory parameters and serum tube agglutination test as markers for brucellosis treatment response

ÇAKIR KIYMAZ Y., ELALDI N.

Microbes and Infection , vol.27, no.8, 2025 (SCI-Expanded, Scopus)

15. Factors predicting the need for surgery in infectious spondylodiscitis: a retrospective single-center study.

Çakır Kıymaz Y., Kıymaz E., Bulut Z., Büyüktuna S. A., Özüm Ü., Elaldı N.

Neurosurgical review , vol.48, no.1, pp.590, 2025 (SCI-Expanded, Scopus)

16. Klinik Örneklerden İzole Edilen Tüberküloz DışıMikobakterilerin MALDI-TOF MS YöntemiyleBelirlenen Tür Dağılımlarının İrdelenmesi

Öksüz C., Çubuk F., Fırtına Topcu K., Hasbek M., Elaldı N., Büyüktuna S. A.

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.30, no.2, pp.184-192, 2025 (ESCI, TRDizin)

17. Klinik Örneklerden İzole Edilen Tüberküloz Dışı Mikobakterilerin MALDI-TOF MS Yöntemiyle Belirlenen Tür Dağılımlarının İrdelenmesi

Öksüz C., Çubuk F., Fırtına Topcu K., Hasbek M., Elaldı N., Büyüktuna S. A.

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.30, no.2, pp.184-189, 2025 (ESCI, TRDizin)

18. Spontaneous bacterial peritonitis due to Brucella in an HBV-positive cirrhotic patient.

Kıymaz Y., Yeşildağ S. K., Baltacı S., Baysal A. Ç., Baysal C., Keskin E., et al.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy , vol.31, no.4, pp.102663, 2025 (SCI-Expanded, Scopus)

19. Research and product development for Crimean–Congo haemorrhagic fever: priorities for 2024–30

Semper A. E., Olver J., Warner J., Cehovin A., Fay P. C., Hart P. J., et al.

The Lancet Infectious Diseases , vol.25, no.4, 2025 (SCI-Expanded, Scopus)

20. Hidden threats: Brucellosis diagnosis and co-infection patterns in Crimean-Congo Hemorrhagic Fever suspects

Öz M., Çubuk F., ÇAKIR KIYMAZ Y., Öksüz C., HASBEK M., BÜYÜKTUNA S. A., et al.

Diagnostic Microbiology and Infectious Disease , vol.111, no.3, 2025 (SCI-Expanded, Scopus)

21. Investigation of The Prevalence of Tick-Borne Encephalitis Virus Antibodies In Patients With Preliminary Diagnosis of Crimean-Congo Hemorrhagic Fever

Öz M., Çakır Kıymaz Y., Öksüz C., Bağcı B., Pektaş A. N., Turan T., et al.

Cumhuriyet Tıp Dergisi (ELEKTRONİK) , vol.47, no.1, pp.22-25, 2025 (Peer-Reviewed Journal)

22. Role of interferon regulatory factors in predicting the prognosis of Crimean-Congo hemorrhagic fever

Öksüz C., DOĞAN H. O., ZARARSIZ G., ELALDI N., Ali Büyüktuna S. A.

Turkish Journal of Biochemistry , vol.50, no.1, pp.99-107, 2025 (SCI-Expanded, Scopus, TRDizin)

23. Evaluation of the clinical characteristics, laboratory parameters, and antibiotic treatment in patients diagnosed with tularemia

Çakır Kıymaz Y., Bolat S., Katırcı B., Aldemir Ö., Altınkaya I., Özcan M. M., et al.

Journal of Infection and Chemotherapy , vol.31, no.2, 2025 (SCI-Expanded, Scopus)

24. Triple threat: Sequential meningitis infections in an immunosuppressed patient with Morganella morganii, Acinetobacter baumannii, and vancomycin-resistant Enterococcus faecium

Kıymaz Y., KIYMAZ E., BULUT Z., BÜYÜKTUNA S. A., ELALDI N.

Diagnostic Microbiology and Infectious Disease , vol.111, no.2, 2025 (SCI-Expanded, Scopus)

25. The great tularemia outbreak in Sivas: Evaluation of 205 cases

Çakır Kıymaz Y., Bolat S., Katırcı B., Aldemir Ö., Altınkaya I., Mustafa Özcan M., et al.

Diagnostic Microbiology and Infectious Disease , vol.111, no.1, 2025 (SCI-Expanded, Scopus)

26. Comparison of Predictive Performances of Machine Learning Methods in the Diagnosis of Crimean-Congo Hemorrhagic Fever

AKAYDIN GÜLTÜRK E., BİRCAN H., KARABULUT E., ELALDI N.

Turkish Journal of Science and Health , vol.6, no.2, pp.52-61, 2025 (Peer-Reviewed Journal)

27. A rare case of necrotizing pneumonia due to brucellosis with blood and urine culture positivity

ÇAKIR KIYMAZ Y., YEŞİLDAĞ S., HASBEK M., BÜYÜKTUNA S. A., ELALDI N.

Diagnostic Microbiology and Infectious Disease , vol.110, no.4, 2024 (SCI-Expanded, Scopus)

28. Development of targeted whole genome sequencing approaches for Crimean-Congo haemorrhagic fever virus (CCHFV).

D'Addiego J., Shah S., Pektaş A. N., Bağci B., Öz M., Sebastianelli S., et al.

Virus research , vol.350, pp.199464, 2024 (SCI-Expanded, Scopus)

29. Convalescent human plasma candidate reference materials protect against Crimean-Congo haemorrhagic fever virus (CCHFV) challenge in an A129 mouse model

Kempster S., Hassall M., Graham V., Kennedy E., Findlay-Wilson S., Salguero F. J., et al.

Virus Research , vol.346, 2024 (SCI-Expanded, Scopus)

30. Crimean–Congo haemorrhagic fever virus uses LDLR to bind and enter host cells

Monteil V. M., Wright S. C., Dyczynski M., Kellner M. J., Appelberg S., Platzer S. W., et al.

Nature Microbiology , vol.9, no.6, pp.1499-1512, 2024 (SCI-Expanded, Scopus)

31. Sivas İlinde Saptanan İmporte Sıtma Vakalarının Değerlendirilmesi

BÜYÜKTUNA S. A., YEŞİLDAĞ S. K., ÇUBUK F., ELALDI N., BAKIR M.

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.29, no.1, pp.69-76, 2024 (ESCI, TRDizin)

32. The Effect of Cycle Threshold Value on Predicting Prognosis in CrimeanCongo Hemorrhagic Fever Disease

Büyüktuna S. A., Çubuk F., Hasbek M., Kara S., Çömez Baysal A., Baysal C., et al.

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.28, no.4, pp.629-636, 2023 (ESCI, TRDizin)

33. Systems-level temporal immune-metabolic profile in Crimean-Congo hemorrhagic fever virus infection

Ambikan A. T., ELALDI N., Svensson-Akusjärvi S., BAĞCI B., PEKTAŞ A. N., Hewson R., et al.

Proceedings of the National Academy of Sciences of the United States of America , vol.120, no.37, 2023 (SCI-Expanded, Scopus)

34. Investigating the effect of ribavirin treatment on genetic mutations in Crimean-Congo haemorrhagic fever virus (CCHFV) through next-generation sequencing.

D'addiego J., Elaldi N., Wand N., Osman K., Bagci B., Kennedy E., et al.

Journal of medical virology , vol.95, no.2, 2023 (SCI-Expanded, Scopus)

35. The investigation of host genetic variants of toll-like receptor 7 and 8 in COVID-19

Bagci G., Gundogdu O., Pektas A. N., Bagci B., Avci O., Gursoy S., et al.

Nucleosides, Nucleotides and Nucleic Acids , vol.42, no.8, pp.586-602, 2023 (SCI-Expanded, Scopus) Sustainable Development

36. A Case of Oropharyngeal Tularemia Mimicking Lymphoma During Pregnancy Gebelikte Lenfomayı Taklit Eden Bir Orofarengeal Tularemi Olgusu

ELALDI N., Öz M., KURT B., Turgut İ., KOÇ T., Turan M., et al.

Mikrobiyoloji bulteni , vol.56, no.4, pp.740-748, 2022 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

37. Which scoring system is effective in predicting mortality in patients with Crimean Congo hemorrhagic fever? A validation study.

Bakir M., Öksüz C., Karakeçili F., Baykam N., Barut Ş., Büyüktuna S. A., et al.

Pathogens and global health , vol.116, no.3, pp.193-200, 2022 (SCI-Expanded, Scopus)

38. Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target.

Neogi U., Elaldi N., Appelberg S., Ambikan A., Kennedy E., Dowall S., et al.

eLife , vol.11, 2022 (SCI-Expanded, Scopus)

39. COVID-19 Co-infection in a patient with Crimean Congo Hemorrhagic Fever: A Case Report

Büyüktuna S. A., Hasbek M., Oksuz C., Baysal C., Öz M., Elaldı N., et al.

MIKROBIYOLOJI BULTENI , vol.55, no.3, pp.445-451, 2021 (SCI-Expanded, Scopus, TRDizin)

40. Development of a novel recombinant ELISA for the detection of Crimean-Congo hemorrhagic fever virus IgG antibodies.

Gülce-İz S., Elaldı N., Can H., Şahar E. A., Karakavuk M., Gül A., et al.

Scientific reports , vol.11, no.1, pp.5936, 2021 (SCI-Expanded, Scopus)

41. Association of MCP-1 promotor polymorphism with disease severity of Crimean-Congo hemorrhagic fever

Bagci B., Bagci G., Buyuktuna S. A., Elaldi N.

JOURNAL OF MEDICAL VIROLOGY , vol.92, no.12, pp.2976-2982, 2020 (SCI-Expanded, Scopus)

42. Klebsiella pneumoniae Infections in the Intensive Care Unit: Risk Factors Related to Carbapenem Resistance and Patient Mortality

Büyüktuna S. A., Hasbek M., Çelik C., Ünlüsavuran M., Avcı O., Baltacı S., et al.

MIKROBIYOLOJI BULTENI , vol.54, no.3, pp.378-391, 2020 (SCI-Expanded, Scopus, TRDizin)

43. Antibiotic usage in hospitalized patients: a one-day point prevalence study

Karabay O., Ince N., Aypak A., Guclu E., BODUR H., USTURALI MUT A. N., et al.

Journal Of Chemotherapy , vol.32, no.4, pp.188-192, 2020 (SCI-Expanded, Scopus)

44. Brucellosis in pregnancy: results of multicenter ID-IRI study.

Inan A., Erdem H., ELALDI N., Gulsun S., Karahocagil M. K., Pekok A. U., et al.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology , vol.38, no.7, pp.1261-1268, 2019 (SCI-Expanded, Scopus) Sustainable Development

45. Epidemiological analysis of Nosocomial Candida infections: Experience of a university hospital

BÜYÜKTUNA S. A., HASBEK M., ELALDI N., Gözel M. G., ÇELİK C., ENGİN A., et al.

Cumhuriyet Medical Journal , vol.41, no.2, pp.318-327, 2019 (TRDizin)

46. Radiological data in microbiologically confirmed central nervous system tuberculosis

KILIÇOĞLU G., ÖZTÜRK ENGİN D., TİRELİ H., CAĞ Y., ŞENGÖZ G., ŞENBAYRAK S., et al.

CLINICAL MICROBIOLOGY AND INFECTION , vol.24, no.10, pp.1109-1110, 2018 (SCI-Expanded, Scopus)

47. The Effect of Bundle Adaptation Control on VAP Speed and Length of Hospital Stay in Avoiding the Ventilator Associated Pneumonia (VAP) at Anesthesia Intensive Care Unit

Karagözoğlu Ş., Tok Yıldız F., Gürsoy S., Gülsoy Z., Süha B. K., Koçyiğit H., et al.

International Journal of Nursing & Clinical Practices , vol.5, no.1, pp.295, 2018 (Peer-Reviewed Journal)

48. The protective effect and diagnostic performance of NOX-5 in Crimean-Congo haemorrhagic fever patients

BÜYÜKTUNA S. A., DOĞAN H. O., BAKIR M., ELALDI N., GÖZEL M. G., ENGİN A.

JOURNAL OF MEDICAL MICROBIOLOGY , vol.67, no.4, pp.543-548, 2018 (SCI-Expanded, Scopus)

49. Cytopenia in adult brucellosis patients

Kaya S., ELALDI N., Deveci O., Eskazan A. E., Bekcibasi M., Hosoglu S.

INDIAN JOURNAL OF MEDICAL RESEARCH , vol.147, pp.73-80, 2018 (SCI-Expanded, Scopus)

50. A rare seen pathogen in complicated skin-soft tissue infection: Pasteurella bettyae

Büyüktuna S. A., Ramazanoğlu Z. B., Elaldı N., Bakıcı M. Z.

Cumhuriyet Medical Journal , vol.39, no.4, pp.692-695, 2017 (TRDizin)

51. Central nervous system infections in the absence of cerebrospinal fluid pleocytosis.

Erdem H., Ozturk-Engin D., Cag Y., Senbayrak S., Inan A., Kazak E., et al.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases , vol.65, pp.107-109, 2017 (SCI-Expanded, Scopus) Sustainable Development

52. Topikal Antimikrobiyaller

Elaldı N.

Turkiye Klinikleri J Inf Dis-Special Topics , vol.10, no.1, pp.136-141, 2017 (TRDizin)

53. International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: Device-associated module

Daniel Rosenthal V., Al-Abdely H. M., El-Kholy A. A., AlKhawaja S. A. A., Leblebicioglu H., Mehta Y., et al.

AMERICAN JOURNAL OF INFECTION CONTROL , vol.44, pp.1495-1504, 2016 (SCI-Expanded, Scopus)

54. Biosafety standards for working with Crimean-Congo hemorrhagic fever virus

Weidmann M., Avsic-Zupanc T., Bino S., Bouloy M., Burt F., Chinikar S., et al.

JOURNAL OF GENERAL VIROLOGY , vol.97, pp.2799-2808, 2016 (SCI-Expanded, Scopus) Sustainable Development

55. Cranial imaging findings in neurobrucellosis: results of Istanbul-3 study

Erdem H., Senbayrak S., Meric K., Batirel A., Karahocagil M. K., Hasbun R., et al.

INFECTION , vol.44, no.5, pp.623-631, 2016 (SCI-Expanded, Scopus)

56. Serum sTREM-1 Level Is Quite Higher in Crimean Congo Hemorrhagic Fever, a Viral Infection

Altay F. A., ELALDI N., Senturk G. C., Altin N., GÖZEL M. G., Albayrak Y., et al.

JOURNAL OF MEDICAL VIROLOGY , vol.88, no.9, pp.1473-1478, 2016 (SCI-Expanded, Scopus)

57. Hydrocephalus and vasculitis delay therapeutic responses in tuberculous meninigitis: Results of Haydarpasa-III study

ÇAĞ Y., Ozturk-Engin D., Gencer S., Hasbun R., Sengoz G., Crisan A., et al.

NEUROLOGY INDIA , vol.64, no.5, pp.896-905, 2016 (SCI-Expanded, Scopus) Sustainable Development

58. Relationship between IFNA1, IFNA5, IFNA10, and IFNA17 gene polymorphisms and Crimean-Congo hemorrhagic fever prognosis in a Turkish population range

ELALDI N., YILMAZ M., BAĞCI B., Yelkovan İ., BAĞCI G., GÖZEL M. G., et al.

JOURNAL OF MEDICAL VIROLOGY , vol.88, no.7, pp.1159-1167, 2016 (SCI-Expanded, Scopus)

59. Causative pathogens and antibiotic resistance in diabetic foot infections: A prospective multi-center study

Hatipoglu M., Mutluoglu M., Turhan V., Uzun G., Lipsky B. A., Sevim E., et al.

JOURNAL OF DIABETES AND ITS COMPLICATIONS , vol.30, no.5, pp.910-916, 2016 (SCI-Expanded, Scopus) Sustainable Development

60. Infections in travellers returning to Turkey from the Arabian peninsula: a retrospective cross-sectional multicenter study

Erdem H., Ak O., Elaldi N., Demirdal T., Hargreaves S., Nemli S. A., et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES , vol.35, no.6, pp.903-910, 2016 (SCI-Expanded, Scopus) Sustainable Development

61. Other Foci of Infections in Community Acquired Central Nervous System Infections

Erdem H., Çağ Y., Şenbayrak S., Engin D. Ö., İnan A., Savaşçı Ü., et al.

Journal of Meningitis , vol.1, no.2, pp.108-111, 2016 (Peer-Reviewed Journal)

62. Managing atypical and typical herpetic central nervous system infections: results of a multinational study

Cag Y., Erdem H., Leib S., Defres S., Kaya S., Larsen L., et al.

CLINICAL MICROBIOLOGY AND INFECTION , vol.22, no.6, 2016 (SCI-Expanded, Scopus)

63. Healthcare-associated Crimean-Congo haemorrhagic fever in Turkey, 2002-2014: a multicentre retrospective cross-sectional study

Leblebicioglu H., Sunbul M., Guner R., Bodur H., Bulut C., Duygu F., et al.

CLINICAL MICROBIOLOGY AND INFECTION , vol.22, no.4, 2016 (SCI-Expanded, Scopus)

64. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study

Yilmaz M., ELALDI N., BALKAN İ. İ., Arslan F., Batirel A. A., BAKICI M. Z., et al.

ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS , vol.15, 2016 (SCI-Expanded, Scopus)

65. Comparison of brucellar and tuberculous spondylodiscitis patients: results of the multicenter "Backbone-1 Study"

Erdem H., ELALDI N., Batirel A., Aliyu S., Sengoz G., Pehlivanoglu F., et al.

SPINE JOURNAL , vol.15, no.12, pp.2509-2517, 2015 (SCI-Expanded, Scopus)

66. Antituberculosis drug resistance patterns in adults with tuberculous meningitis: results of haydarpasa-iv study

Senbayrak S., ÖZKÜTÜK N., Erdem H., Johansen I. S., Civljak R., İNAL A. S., et al.

ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS , vol.14, 2015 (SCI-Expanded, Scopus)

67. Crimean-Congo haemorrhagic fever and secondary bacteraemia in Turkey

SÜNBÜL M., Leblebicioglu H., Fletcher T. E., ELALDI N., ÖZKURT Z., Bastug A., et al.

JOURNAL OF INFECTION , vol.71, no.5, pp.597-599, 2015 (SCI-Expanded, Scopus)

68. Bir Üniversite Hastanesinde Vankomisine Dirençli Enterokok Epidemisi Risk Faktörlerinin Araştırılması

ŞEN M., ELALDI N., GÖZEL M. G., ÇELİK C., ENGİN A., BAKIR M., et al.

Flora Dergisi , vol.20, no.3, pp.140-149, 2015 (Peer-Reviewed Journal)

69. Rotavirus and adenovirus gastroenteritis: time series analysis

ÇELİK C., GÖZEL M. G., TÜRKAY H., BAKICI M. Z., GÜVEN A. S., ELALDI N.

PEDIATRICS INTERNATIONAL , vol.57, no.4, pp.590-596, 2015 (SCI-Expanded, Scopus)

70. Stenotrophomonas maltophilia Infections in Adults: Primary Bacteremia and Pneumonia

GÖZEL M. G., ÇELİK C., ELALDI N.

JUNDISHAPUR JOURNAL OF MICROBIOLOGY , vol.8, no.8, 2015 (SCI-Expanded, Scopus)

71. Vancomycin Resistant Enterococcus Outbreak in a University Hospital: Investigation of Risk Factors

Şen M., Elaldı N., Gözel M. G., Çelik C., Engin A., Bakır M., et al.

FLORA-INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.20, no.3, pp.140-149, 2015 (ESCI, TRDizin)

72. Elevated chemokine levels during adult but not pediatric Crimean-Congo hemorrhagic fever

ARASLI M., ÖZSÜREKCİ Y., ELALDI N., McAuley A. J., Oncel E. K., TEKİN İ. Ö., et al.

JOURNAL OF CLINICAL VIROLOGY , vol.66, pp.76-82, 2015 (SCI-Expanded, Scopus)

73. Hamsi scoring in the prediction of unfavorable outcomes from tuberculous meningitis: results of Haydarpasa-II study

Erdem H., Ozturk-Engin D., Tireli H., Kilicoglu G., Defres S., Gulsun S., et al.

JOURNAL OF NEUROLOGY , vol.262, no.4, pp.890-898, 2015 (SCI-Expanded, Scopus) Sustainable Development

74. Novel Antibiotics on the Horizon, 2015

Elaldı N.

FLORA-INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.20, no.1, pp.1-9, 2015 (ESCI, TRDizin)

75. Effect of tumour necrosis factor-alpha and interleukin-6 promoter polymorphisms on course of Crimean-Congo hemorrhagic fever in Turkish patients.

YILMAZ M., ELALDI N., BAĞCI B., SARI İ., GÜMÜŞ E., Yelkovan İ.

Journal of vector borne diseases , vol.52, no.1, pp.30-5, 2015 (SCI-Expanded, Scopus)

76. Ufuktaki Yeni Antibiyotikler 2015

ELALDI N.

Flora Dergisi , vol.20, no.1, pp.1-9, 2015 (Peer-Reviewed Journal)

77. Evaluation of tularaemia courses: a multicentre study from Turkey.

Erdem H., Ozturk-Engin D., Yesilyurt M., Karabay O., Elaldi N., Celebi G., et al.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases , vol.20, no.12, 2014 (SCI-Expanded, Scopus)

78. Genitourinary brucellosis: results of a multicentric study

Erdem H., Elaldi N., Ak O., Gulsun S., Tekin R., Ulug M., et al.

CLINICAL MICROBIOLOGY AND INFECTION , vol.20, no.11, 2014 (SCI-Expanded, Scopus)

79. The microbiological diagnosis of tuberculous meningitis: results of Haydarpasa-1 study

Erdem H., Ozturk-Engin D., Elaldi N., Gulsun S., Sengoz G., Crisan A., et al.

CLINICAL MICROBIOLOGY AND INFECTION , vol.20, no.10, 2014 (SCI-Expanded, Scopus)

80. International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module

Rosenthal V. D., Maki D. G., Mehta Y., Leblebicioglu H., Memish Z. A., Al-Mousa H. H., et al.

AMERICAN JOURNAL OF INFECTION CONTROL , vol.42, no.9, pp.942-956, 2014 (SCI-Expanded, Scopus)

81. The features of infectious diseases departments and anti-infective practices in France and Turkey: a cross-sectional study.

Erdem H., Stahl J. P., Inan A., Kilic S., Akova M., Rioux C., et al.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology , vol.33, no.9, pp.1591-9, 2014 (SCI-Expanded, Scopus)

82. Liver involvement in patients with brucellosis: results of the Marmara study

Ozturk-Engin D., Erdem H., Gencer S., Kaya S., Baran A. I., Batirel A., et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES , vol.33, no.7, pp.1253-1262, 2014 (SCI-Expanded, Scopus) Sustainable Development

83. Evaluation of Clinical and Laboratory Findings of Pediatric and Adult Patients with Oropharyngeal Tularemia in Turkey: a Combination of Surgical Drainage and Antibiotic Therapy Increases Treatment Success

GÖZEL M. G., ENGİN A., ALTUNTAŞ E. E., ŞALK İ., KAYA A., Ceik C., et al.

JAPANESE JOURNAL OF INFECTIOUS DISEASES , vol.67, no.4, pp.295-299, 2014 (SCI-Expanded, Scopus)

84. Sequential determination of serum viral titers, virus-specific IgG antibodies, and TNF-alpha, IL-6, IL-10, and IFN-gamma levels in patients with Crimean-Congo hemorrhagic fever

Kaya S., Elaldı N., Kubar A., Gürsoy N., Yılmaz M., Karakuş G., et al.

BMC INFECTIOUS DISEASES , vol.14, 2014 (SCI-Expanded, Scopus)

85. Crimean Congo Hemorrhagic Fever

ELALDI N., Kaya Ş.

Journal of Microbiology and Infectious Diseases , vol.4, no.5, pp.1-9, 2014 (TRDizin)

86. Surveillance, control and management of infections in intensive care units in Southern Europe, Turkey and Iran - A prospective multicenter point prevalence study

Erdem H., Inan A., ALTINDİŞ S., Carevic B., Askarian M., Cottle L., et al.

JOURNAL OF INFECTION , vol.68, no.2, pp.131-140, 2014 (SCI-Expanded, Scopus) Sustainable Development

87. Mortality indicators in pneumococcal meningitis: therapeutic implications

Erdem H., ELALDI N., Oztoprak N., Sengoz G., Ak O., KAYA S., et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , vol.19, pp.13-19, 2014 (SCI-Expanded, Scopus)

88. Update on treatment options for spinal brucellosis

Ulu-Kilic A., Karakas A., Erdem H., Turker T., Inal A. S., Ak O., et al.

CLINICAL MICROBIOLOGY AND INFECTION , vol.20, no.2, 2014 (SCI-Expanded, Scopus)

89. Plasma Oxidative Stress and Total Thiol Levels in Crimean-Congo Hemorrhagic Fever

Karadag-Oncel E., Erel O., ÖZSÜREKCİ Y., Caglayik D. Y., KAYA A., Gozeol M. G., et al.

JAPANESE JOURNAL OF INFECTIOUS DISEASES , vol.67, no.1, pp.22-26, 2014 (SCI-Expanded, Scopus)

90. Respiratory System Involvement in Brucellosis The Results of the Kardelen Study

Erdem H., Inan A., ELALDI N., TEKİN R., Gulsun S., Ataman-Hatipoglu C., et al.

CHEST , vol.145, no.1, pp.87-96, 2014 (SCI-Expanded, Scopus)

91. Infectious Diseases Departments and Patients in the University Hospitals in Turkey

ERDEM H., Derya D. Ö., Tuna N., KURTARAN B., PARLAK E., HOŞOĞLU S., et al.

Journal of Infectious Diseases and Therapeutics , vol.2, no.1, pp.22-7, 2014 (Peer-Reviewed Journal) Sustainable Development

92. Increasing antimicrobial resistance in nosocomial pathogens multidrug resistant extensively drug resistant and pandrug resistant Acinetobacter baumannii

ÇELİK C., GÖZEL M. G., Füsun D., BAKICI M. Z., ELALDI N., GÜLTÜRK E.

Journal of Microbiology and Infectious Diseases , vol.4, no.1, pp.7-12, 2014 (TRDizin)

93. Investigation of Crimean-Congo Hemorrhagic Fever Virus Transmission from Patients to Relatives: A Prospective Contact Tracing Study

Gözel M. G., Bakır M., Öztop A. Y., Engin A., Dökmetaş İ., Elaldı N.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE , vol.90, no.1, pp.160-162, 2014 (SCI-Expanded, Scopus)

94. Favorable Outcomes for both Mother and Baby Are Possible in Pregnant Women with Crimean-Congo Hemorrhagic Fever Disease: A Case Series and Literature Review

GÖZEL M. G., ELALDI N., ENGİN A., BOZOKLU AKKAR Ö., BOLAT F., ÇELİK C.

GYNECOLOGIC AND OBSTETRIC INVESTIGATION , vol.77, no.4, pp.266-271, 2014 (SCI-Expanded, Scopus) Sustainable Development

95. Community-acquired pneumonia in patients with chronic obstructive pulmonary disease requiring admission to the intensive care unit: Risk factors for mortality

ÇİLLİ A., Erdem H., Karakurt Z., Turkan H., Yazicioglu-Mocin O., Adiguzel N., et al.

JOURNAL OF CRITICAL CARE , vol.28, no.6, pp.975-979, 2013 (SCI-Expanded, Scopus)

96. Can the Mild Clinical Course of Crimean-Congo Hemorrhagic Fever in Children Be Explained by Cytokine Responses?

ÖZSÜREKCİ Y., ARASLI M., Oncel E. K., Caglayik D. Y., KAYA A., İÇAĞASIOĞLU F. D., et al.

JOURNAL OF MEDICAL VIROLOGY , vol.85, no.11, pp.1955-1959, 2013 (SCI-Expanded, Scopus)

97. Withdrawal of Staphylococcus aureus from intensive care units in Turkey

Erdem H., DİZBAY M., Karabey S., KAYA S., DEMİRDAL T., Koksal I., et al.

AMERICAN JOURNAL OF INFECTION CONTROL , vol.41, no.11, pp.1053-1058, 2013 (SCI-Expanded, Scopus)

98. Recommended precaution procedures protect healthcare workers from Crimean-Congo hemorrhagic fever virus

Gözel M. G., Dökmetaş İ., Öztop A. Y., Engin A., Elaldı N., Bakır M.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , vol.17, no.11, 2013 (SCI-Expanded, Scopus)

99. Antimicrobial Resistance Patterns of Enterococcus faecalis and Enterococcus faecium Bacteria Isolated from Bloodstream Infections

Çelik C., Uysal E. B., Gözel G., Bakıcı M. Z., Elaldı N.

FLORA-INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.18, no.2, pp.83-89, 2013 (SCI-Expanded, TRDizin)

100. Mortality indicators in community-acquired pneumonia requiring intensive care in Turkey

Erdem H., Turkan H., ÇİLLİ A., Karakas A., Karakurt Z., BİLGE U., et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , vol.17, no.9, 2013 (SCI-Expanded, Scopus)

101. Brucellar pericarditis: a report of four cases and review of the literature

Kaya S., Eskazan A. E., ELALDI N.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , vol.17, no.6, 2013 (SCI-Expanded, Scopus)

102. Kan dolaşımı enfeksiyonlarından izole edilen Enterococcus faecalis ve Enterococcus faecium bakterilerinin antimikrobiyal direnç paterni

ÇELİK C., UYSAL E. B., GÖZEL M. G., BAKICI M. Z., ELALDI N.

Flora , vol.18, no.2, pp.83-89, 2013 (Peer-Reviewed Journal)

103. Community-acquired CTX-M-15-type ESBL-producing Escherichia coli meningitis: a case report and literature review

ELALDI N., GÖZEL M. G., KOLAYLI F., ENGİN A., ÇELİK C., BAKICI M. Z., et al.

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES , vol.7, no.5, pp.424-431, 2013 (SCI-Expanded, Scopus)

104. Isolation and Identification of Free-Living Amoebae from Tap Water in Sivas, Turkey

Coskun K. A., ÖZÇELİK S., Tutar L., ELALDI N., TUTAR Y.

BIOMED RESEARCH INTERNATIONAL , 2013 (SCI-Expanded, Scopus) Sustainable Development

105. First cases of hemorrhagic fever with renal syndrome from the middle anatolia region of Turkey and the first case of hantavirus and crimean-congo hemorrhagic fever virus co-infection in a patient Türkiye'nin Orta Anadolu Bölgesi'nden Renal Sendromlu İlk Kanamalı Ateş Olguları ve Hanta Virüs ile Kırım Kongo Kanamalı Ateş Virüsü Koenfeksiyonu Olan İlk Olgu

Gözel M. G., ENGİN A., ELALDI N., BAKIR M., Dökmetaş I., Uyar Y.

Turkiye Klinikleri Journal of Medical Sciences , vol.33, no.1, pp.224-228, 2013 (SCI-Expanded, Scopus)

106. First Cases of Hemorrhagic Fever with Renal Syndrome from the Middle Anatolia Region of Turkey and the First Case of Hantavirus and Crimean Congo Hemorrhagic Fever Virus Co Infection in a Patient

GÖZEL M. G., ENGİN A., ELALDI N., BAKIR M., Dökmetaş İ., UYAR Y.

Turkiye Klinikleri J Med Sci , vol.33, no.1, pp.224-8, 2013 (Peer-Reviewed Journal)

107. Case Management and Supportive Treatment for Patients with Crimean-Congo Hemorrhagic Fever

Leblebicioglu H., Bodur H., Dokuzoguz B., ELALDI N., Guner R., Koksal I., et al.

VECTOR-BORNE AND ZOONOTIC DISEASES , vol.12, no.9, pp.805-811, 2012 (SCI-Expanded, Scopus)

108. A new perspective to determine the severity of cases with Crimean-Congo hemorrhagic fever

BAKIR M., ENGİN A., GÖZEL M. G., ELALDI N., KILIÇKAP S., ÇINAR Z.

JOURNAL OF VECTOR BORNE DISEASES , vol.49, no.2, pp.105-110, 2012 (SCI-Expanded, Scopus)

109. Antimicrobial Susceptibility and Frequency of Extended Spectrum Beta-Lactamase (ESBL) of Escherichia coli Strains Isolated from Community Acquired and Nosocomial Infections

Gözel G., Elaldı N., Korğalı E., Engin A., Çelik C., Bakır M., et al.

FLORA-INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.17, no.2, pp.75-81, 2012 (SCI-Expanded, TRDizin)

110. Unusual manifestations of acute Q fever: autoimmune hemolytic anemia and tubulointerstitial nephritis

KORKMAZ S., ELALDI N., KAYATAŞ M., ŞENCAN M., YILDIZ E.

ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS , vol.11, 2012 (SCI-Expanded, Scopus)

111. Efficacy and Tolerability of Antibiotic Combinations in Neurobrucellosis: Results of the Istanbul Study

Erdem H., Ulu-Kilic A., Kilic S., Karahocagil M., Shehata G., Eren-Tulek N., et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , vol.56, no.3, pp.1523-1528, 2012 (SCI-Expanded, Scopus)

112. Pneumococcal Meningitis in 18 Year-Old Young Pregnant Woman

Gözel G., Elaldı N., Büyükhan İ., Engin A., Bakır M., Dökmetaş İ.

FLORA-INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.17, no.1, pp.46-50, 2012 (SCI-Expanded, TRDizin)

113. EVALUATION OF RESPIRATORY FINDINGS IN CRIMEAN-CONGO HEMORRHAGIC FEVER

DOĞAN Ö. T., ENGİN A., ŞALK İ., EPÖZTÜRK K., EREN Ş. H., ELALDI N., et al.

SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH , vol.42, no.5, pp.1100-1105, 2011 (SCI-Expanded, Scopus) Sustainable Development

114. Doripenem: Geniş spektrumlu karbapenem yapılı yeni antibiyotik

Elaldı N.

Flora , vol.16, no.1, pp.1-17, 2011 (SCI-Expanded, Scopus)

115. Crimean-Congo hemorrhagic fever disease due to tick bite with very long incubation periods

KAYA A., ENGİN A., GÜVEN A. S., İÇAĞASIOĞLU F. D., CEVİT Ö., ELALDI N., et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , vol.15, no.7, 2011 (SCI-Expanded, Scopus)

116. The first tularemia outbreak in the sivas province: A review of 29 cases Sivas Ilinde saptanan Ilk tularemi salgını: 29 olgunun deǧerlendirilmesi

Engin A., Altuntaş E. E., Cankorkmaz L., Kaya A., Elaldı N., Şimşek H., et al.

Klimik Dergisi , vol.24, pp.17-23, 2011 (SCI-Expanded, Scopus, TRDizin)

117. Sivas İlinde Saptanan İlk Tularemi Salgını:29 Olgunun Değerlendirilmesi

ENGİN A., ALTUNTAŞ E. E., CANKORKMAZ L., Kaya A., ELALDI N., ŞİMŞEK H., et al.

KLIMIK DERGISI , vol.24, no.1, pp.17-23, 2011 (ESCI, Scopus, TRDizin)

118. Assessment of the requisites of microbiology based infectious disease training under the pressure of consultation needs

Erdem H., Tekin-Koruk S., Koruk I., Tozlu-Keten D., Ulu-Kilic A., Oncul O., et al.

ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS , vol.10, 2011 (SCI-Expanded, Scopus) Sustainable Development

119. Serum Levels of Mannan-Binding Lectin in Patients with Crimean-Congo Hemorrhagic Fever

ENGİN A., UĞURLU S., Caglar E., ÖZTOP A. Y., İNAN D., ELALDI N., et al.

VECTOR-BORNE AND ZOONOTIC DISEASES , vol.10, no.10, pp.1037-1041, 2010 (SCI-Expanded, Scopus) Sustainable Development

120. Toll-like receptor 8 and 9 polymorphisms in Crimean-Congo hemorrhagic fever

ENGİN A., ARSLAN S., Kizildag S., Ozturk H., ELALDI N., DÖKMETAŞ İ., et al.

MICROBES AND INFECTION , vol.12, pp.1071-1078, 2010 (SCI-Expanded, Scopus)

121. Cutaneous Anthrax in the Central Anatolia Region of Turkey: A Review of 39 Adults Cases

ENGİN A., ELALDI N., DÖKMETAŞ İ., BAKICI M. Z., Kaya S., BAKIR M.

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , vol.30, no.3, pp.1032-1038, 2010 (SCI-Expanded, Scopus)

122. Community acquired acute bacterial meningitis in the elderly in Turkey

ERDEM H., KILIÇ S., COŞKUN Ö., ERSOY Y., ÇAĞATAY A. A., Öngürü P., et al.

Clin Microbiol Infect , vol.16, no.8, pp.1223-9, 2010 (SCI-Expanded)

123. Response to Ergonul: Scientific Evidence Versus Personal Beliefs In Crimean-Congo Haemorrhagic Fever Treatment

Ascioglu S., Leblebicioglu H., ELALDI N., Bodur H., Vahaboglu H.

JOURNAL OF INFECTION , vol.59, no.4, pp.286-289, 2009 (SCI-Expanded, Scopus)

124. Ethical concern Response

Ascioglu S., ELALDI N., Bodur H., Vahaboglu H., Leblebicioglu H.

JOURNAL OF INFECTION , vol.59, no.4, pp.290-291, 2009 (SCI-Expanded, Scopus)

125. Cytochrome P450 2D6 and MDR1 Gene Mutation in Relation to Mortality in Patients with Crimean-Congo Hemorrhagic Fever: A Preliminary Study

ENGİN A., Koksal B., DOĞAN Ö. T., ELALDI N., DÖKMETAŞ İ., BAKIR M., et al.

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , vol.29, no.4, pp.905-910, 2009 (SCI-Expanded, Scopus)

126. Crimean-Congo hemorrhagic fever: does it involve the heart?

ENGİN A., YILMAZ M. B., ELALDI N., ERDEM A., YALTA K., TANDOĞAN İ., et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , vol.13, no.3, pp.369-373, 2009 (SCI-Expanded, Scopus)

127. Ocular Findings in Patients with Crimean-Congo Hemorrhagic Fever

ENGİN A., ERDOĞAN H., Ozec A. V., ELALDI N., TOKER M. İ., BAKIR M., et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY , vol.147, no.4, pp.634-638, 2009 (SCI-Expanded, Scopus)

128. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: A quasi-experimental study from Turkey

ELALDI N., Bodur H., Ascioglu S., Celikbas A., ÖZKURT Z., Vahaboglu H., et al.

JOURNAL OF INFECTION , vol.58, no.3, pp.238-244, 2009 (SCI-Expanded, Scopus)

129. Crimean-Congo Hemorrhagic Fever Virus in High-Risk Population, Turkey

Gunes T., Engin A., Poyraz O., ELALDI N., Kaya S., Dokmetas I., et al.

EMERGING INFECTIOUS DISEASES , vol.15, no.3, pp.461-464, 2009 (SCI-Expanded, Scopus)

130. A preliminary study to evaluate the effect of intravenous ribavirin treatment on survival rates in Crimean-Congo hemorrhagic fever

Cevik M. A., Elaldi N., Akinci E., Oenguerue P., Erbay A., Buzgan T., et al.

JOURNAL OF INFECTION , vol.57, no.4, pp.350-351, 2008 (SCI-Expanded, Scopus)

131. Tick paralysis with atypical presentation: isolated, reversible involvement of the upper trunk of brachial plexus

Engin A., Elaldi N., Bolayir E., Dokmetas I., Bakir M.

EMERGENCY MEDICINE JOURNAL , vol.23, no.7, 2006 (SCI-Expanded, Scopus)

132. Brucellosis: An electroneuromyography study

Bolayir E., Elaldi N., Uz U., Coemez N., Bakir M.

NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH , vol.13, no.2, pp.71-74, 2006 (SCI-Expanded, Scopus) Sustainable Development

133. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey

Arslan H., Azap Ö. K., Ergönül Ö., Timurkaynak F., Aydin K., Bakir M., et al.

Journal of Antimicrobial Chemotherapy , vol.56, no.5, pp.914-918, 2005 (SCI-Expanded, Scopus)

134. Effects of giardiasis on school success, weight and height indices of primary school children in Turkey

Celiksoz A., Acioz M., Degerli S., Cinar Z., Elaldi N., Erandac M.

PEDIATRICS INTERNATIONAL , vol.47, no.5, pp.567-571, 2005 (SCI-Expanded, Scopus)

135. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures

Bakir M., Ugurlu M., Dokuzoguz B., Bodur H., Tasyaran M., Vahaboglu H.

JOURNAL OF MEDICAL MICROBIOLOGY , vol.54, no.4, pp.385-389, 2005 (SCI-Expanded, Scopus)

136. Effect of bile duct obstruction on the biliary secretion of meropenem in rats

Elaldi N., Soydan S., Turan M., Duman M., Goktas S., Topcu Ö., et al.

CHIRURGISCHE GASTROENTEROLOGIE , vol.21, no.3, pp.280-284, 2005 (SCI-Expanded, Scopus)

137. Kırım-Kongo Hemorajik Ateşi epidemiyolojisi

Elaldı N.

KLIMIK JOURNAL , vol.17, no.3, pp.151-156, 2004 (ESCI, Scopus)

138. An unusual cause of cholecystitis: a worm in the bag

Elaldi N., Turan M., Arslan M., Dokmetas I., Bakir M.

EMERGENCY MEDICINE JOURNAL , vol.20, no.5, pp.489-490, 2003 (SCI-Expanded, Scopus)

139. Hemofagositik sendrom: Olgu sunumu

Elaldı N.

ERCIYES MEDICAL JOURNAL , vol.25, no.2, pp.104-110, 2003 (SCI-Expanded, TRDizin)

140. Hemophagocytic syndrome: A report of two cases Hemofagosi̇ti̇k sendrom: İki̇ olgu sunumu

Elaldi N., Şencan M., Alagözlü H., Dökmetaş I., Bakir M., Bilgiç A.

Erciyes Tip Dergisi , vol.25, no.2, pp.104-110, 2003 (SCI-Expanded, Scopus, TRDizin)

141. Diabetic ketoacidosis and rhino-orbital mucormycosis

Dokmetas H., Canbay E., Yilmaz S., Elaldi N., Topalkara A., Oztoprak I., et al.

DIABETES RESEARCH AND CLINICAL PRACTICE , vol.57, no.2, pp.139-142, 2002 (SCI-Expanded, Scopus) Sustainable Development

142. A survey of patients with acute poisoning in the Sivas region, Turkey, between 1994 and 1998

Alagözlü H., Sezer H., CANDAN F., Tabak E., ELALDI N.

Turkish Journal of Medical Sciences , vol.32, no.1, pp.39-42, 2002 (SCI-Expanded, Scopus, TRDizin)

143. A Survey of patients with acute poisoning in Sivas region Turkey between the years 1994 and 1998

ALAGÖZLÜ H., SEZER H., CANDAN F., TABAK E., ELALDI N.

Turkish Journal of Medical Sciences , no.32, pp.39-42, 2002 (Scopus, TRDizin)

144. Pancreatic pseudotumor due to peripancreatic tuberculous lymphadenitis

Turan M., Sen M., Koyuncu A., Aydin C., Elaldi N., Arici S.

PANCREATOLOGY , vol.2, no.6, pp.561-564, 2002 (SCI-Expanded, Scopus) Sustainable Development

145. Antimicrobial susceptibility of Bacillus anthracis in an endemic area.

Bakici M., Elaldi N., Bakir M., Dokmetas I., Erandac M., Turan M.

Scandinavian journal of infectious diseases , vol.34, no.8, pp.564-6, 2002 (SCI-Expanded, Scopus)

146. The Frequency of Asymptomatic Bacteriuria in Patients with Diabetes Mellitus and Relation with the Duration of Diabetes

Görmüş T., Bakır M., Elaldı N., Dökmetaş İ.

FLORA-INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.6, no.4, pp.240-248, 2001 (SCI-Expanded, TRDizin)

147. In-vitro effect of granulocyte-colony stimulating factor on the neutrophil functions of the patients with chronic renal failure Granülosit-koloni stimülan faktörün kronik böbrek yetmezlikli hastalarin nötrofil fonksiyonlari üzerine in-vitro etkisi

Dazkir D., Bakir M., Dökmetaş I., Elaldi N.

Mikrobiyoloji Bulteni , vol.35, no.1, pp.99-108, 2001 (SCI-Expanded, Scopus, TRDizin)

148. Rapid diagnosis of catheter related sepsis in hemodialysis patients

ELALDI N., BAKIR M., Dökmetaş I.

Erciyes Tip Dergisi , vol.23, no.3, pp.105-110, 2001 (SCI-Expanded, Scopus, TRDizin)

149. Tuberculous pericarditis: A report of three cases

Gultekin F., Bakici M., Elaldi N., Bakir M.

CURRENT MEDICAL RESEARCH AND OPINION , vol.17, no.2, pp.142-145, 2001 (SCI-Expanded, Scopus)

150. Hemodiyaliz hastaları ve santral venöz kateter bağlantılı infeksiyonlar

Elaldı N., Bakır M., Dökmetaş İ., Manduz Ş., Candan F., Karadağ Ö.

Flora , vol.5, no.4, pp.238-245, 2000 (SCI-Expanded, Scopus)

151. Cerrahi Antimikrobiyal Profilaksi ve İstenmeyen Etkiler

Elaldı N.

Flora , vol.5, no.4, pp.215-219, 2000 (SCI-Expanded, Scopus)

152. Bölgemizdeki Streptococcus pneumoniae suşlarının bazı antibiyotiklere direnç durumu

Elaldı N.

KLIMIK JOURNAL , vol.12, no.1, pp.13-15, 1999 (ESCI, Scopus)

153. İn-vitro koşullarda flukonazol ve ketokonazol ile Granülosit-Koloni Stimüle Edici Faktör kombinasyonunun insan nötrofil fonksiyonları üzerine etkisi.

Elaldı N.

KLIMIK JOURNAL , vol.12, no.1, pp.18-23, 1999 (ESCI, Scopus)

154. İn-vitro koşullarda Granülosit-Koloni Stimüle Edici Faktör’ ün amfoterisin B ve lipozomal amfoterisin B ile kombinasyonunun insan nötrofil fonksiyonları üzerine etkisi

Elaldı N.

KLIMIK JOURNAL , vol.11, no.3, pp.103-108, 1998 (ESCI, Scopus)

155. Sağlık personelinde Hepatit B ve C seroprevalansı

Elaldı N.

Mikrobiyoloji Bulteni , vol.29, no.3, pp.278-283, 1995 (SCI-Expanded, Scopus, TRDizin)

156. Gastroenteritli 100 olguda parazit ve maya hücrelerinin rolü.

Elaldı N.

Türkiye Parazitoloji Dergisi , vol.18, no.4, pp.475-478, 1994 (Scopus, TRDizin)

Papers Presented at Peer-Reviewed Scientific Conferences 42

1. Ağır Seyirli Kırım Kongo Kanamalı Ateşi Hastalarında Plazma Değişimi Tedavisi

ÇAKIR KIYMAZ Y., BÜYÜKTUNA S. A., FIRTINA TOPCU K., ŞENCAN M., ÖZDEMİR KOL İ., ELALDI N.

II. Viral İnfeksiyonlar ve Bağışıklama Simpozyumu, Ankara, Turkey, 18 - 20 September 2025, (Summary Text)

2. Geriatrik Bir Hastada Jeneralize Tetanoz Olgusu

ÇAKIR KIYMAZ Y., AYDEMİR B., BAYSAL C., ÖZDEMİR KOL İ., BÜYÜKTUNA S. A., ELALDI N.

25. Türkiye Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları (KLİMİK) Kongresi, Antalya, Turkey, 24 - 27 April 2025, (Summary Text)

3. Triple threat: sequential meningitis infections in an immunosuppressed patient with Morganella morganii, Acinetobacter baumannii, and vancomycin-resistant Enterococcus faecium

ÇAKIR KIYMAZ Y., KIYMAZ E., BULUT Z., BÜYÜKTUNA S. A., ELALDI N.

Europen Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2025, Viyana, Austria, 11 - 15 April 2025, (Summary Text)

4. Sivas’ta Görülen Büyük Tularemi Salgını: 205 Olgunun Değerlenirilmesi

Çakır Kıymaz Y., Bolat S., Aydemir B., Gülgeç Ö., Altınkaya I., Özcan M. M., et al.

25. Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları (KLİMİK) Kongresi, Antalya, Turkey, 24 - 27 April 2025, (Summary Text)

5. Bir Üniversite Hastanesinde PCP Olgularının Değerlendirilmesi

ÖZ M., KESKİN E., ÇAKIR Y., BAYSAL C., BOZKURT S., ÇUBUK F., et al.

11. BUHASDER KONGRESİ, İzmir, Turkey, 29 October 2023, (Summary Text)

6. Bir Üniversite Hastanesinde Takip Edilen HIV Pozitif Hastalarda Tedavi Değişikliklerinin Değerlendirilmesi

BOZKURT S., ÖZ M., YEŞİLDAĞ S., ÇÖMEZ A., BAYSAL C., KESKİN E., et al.

24. Türkiye Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları (KLİMİK) Kongresi, Antalya, Turkey, 06 March 2024, (Summary Text)

7. MALİGNİTEYİ TAKLİT EDEN BİR GEBELİK VE OROFARENGEAL TULAREMİ OLGUSU

ÖZ M., ÇÖMEZ A., KURT B., KOÇ T., TURAN M., BÜYÜKTUNA S. A., et al.

10.TÜRKİYE EKMUD BİLİMSEL KONGRESİ, Antalya, Turkey, 25 May 2022, (Summary Text)

8. TOLL-BENZERİ RESEPTÖR 7 ve 8 POLİMORFİZMLERİNİN COVİD-19 ŞİDDETİ İLE İLİŞKİSİ

Bağcı G., Gündoğdu O., Pektaş A. N., Bağcı B., Avcı O., Gürsoy S., et al.

7. Türkiye in vitro Diyagnostik (IVD) Sempozyumu, İzmir, Turkey, 27 - 29 April 2022, pp.1, (Summary Text)

9. Kırım Kongo Kanamalı Ateşi Hastalarında Ct (Cycle Treshold) Değerlerinin Prognozu Öngörmede Etkisi

Büyüktuna S. A., Hasbek M., Kara S., Çömez A., Baysal C., Keskin E., et al.

9.BUHASDER KONGRESİ, Antalya, Turkey, 24 - 28 November 2021, pp.362-363, (Summary Text)

10. Bölgemizde Kırım-Kongo Kanamalı Ateşli Hasta Sayısı Neden Artmaktadır?

ÖKSÜZ C., BAKIR M., BÜYÜKTUNA S. A., ELALDI N., ENGİN A.

9. TÜRKİYE EKMUD ULUSLARARASI BİLİMSEL PLATFORMU 20-23 MAYIS 2021 - ONLINE KONGRE, Turkey, 20 May 2021, vol.10, pp.99-100, (Summary Text)

11. Yoğun Bakım Ünitesinde İzlenen Kırım-Kongo KanamalıAteşi Hastalarının Analizi

Öksüz C., BAKIR M., BÜYÜKTUNA S. A., AVCI O., ENGİN A., ELALDI N.

8. Türkiye Ekmud Bilimsel Kongresi, online kongre, Sivas, Turkey, 24 - 29 November 2020, vol.9, (Summary Text)

12. Ülkemiz Hastanelerinde Yatan Hastalarda Antibiyotik Kullanımı: Tek Günlük Prevalans Gerçeği. SS138.

KARABAY O., İNCE N., AYPAK A., GÜÇLÜ E., BODUR H., MEMİKOĞLU O., et al.

7. Türkiye Ekmud Uluslararası Kongresi 8-13 Mayıs 2018 Antalya, 8 - 13 May 2018, (Summary Text)

13. Kırım Kongo Kanamalı Ateşi Hastalarında Galectin-1 - Galectin-3 Düzeyleri ve Bu Parametrelerin Mortalite ile İlişkisi

RAMAZANOĞLU Z. B., BAKIR M., BÜYÜKTUNA S. A., DOĞAN H. O., ENGİN A., ELALDI N.

BUHASDER Kongresi 8. Tepecik Enfeksiyon Günleri, İzmir, Turkey, 16 - 20 October 2019, pp.322, (Summary Text)

14. Current Epidemiological, Clinical Situation and PreventiveMethods of CCHF in Turkey

ELALDI N.

7. Türkiye Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Uzmanlık Derneği (EKMUD) Platformu, Ulusrarası Kongre, Antalya, Turkey, 3 - 07 April 2019, vol.8, pp.26, (Summary Text)

15. The effect of bundle adaptation control on ventilator associated pneumonia (VAP) speed and length of hospital stay in avoiding the VAP at anesthesia intensive care unit

KARAGÖZOĞLU Ş., TOK YILDIZ F., GÜRSOY S., SÜHA B. K., gülsoy z., ELALDI N., et al.

World Congress on Nursing and Healthcare, 4 - 06 June 2018, (Full Text)

16. Ülkemiz Hastanelerinde Yatan Hastalarda Antibiyotik Kullanımı: Tek Günlük Prevalans Gerçeği

KARABAY O., İNCE N., AYPAK A., GÜÇLÜ E., BODUR H., MEMİKOĞLU K. O., et al.

7. Türkiye EKMUD Uluslararası Kongresi 8-13 Mayıs 2018., Antalya, Turkey, 8 - 13 May 2018, vol.7, pp.93-94, (Summary Text)

17. The effect of bundle adaptation control on Ventilator Associated Pneumonia (VAP) speed and length of hospital stay in avoiding the VAP at anesthesia intensive care unit

KARAGÖZOĞLU Ş., TOK YILDIZ F., GÜRSOY S., SÜHA B. K., GÜLSOY Z., ELALDI N., et al.

World Congress on Nursing & Healthcare, Denmark, 06 June 2018, (Summary Text)

18. Association of monocyte chemoattractant protein (MCP)-1 promotor polymorphism with Crimean-Congo Hemorrhagic Fever disease severity

BAĞCI B., BAĞCI G., ELALDI N.

6th international molecular biology and biotechnology congress, Afyon, Turkey, 22 - 25 December 2017, vol.1, pp.27, (Summary Text)

19. Immunotherapy in CCHF: why, when and which patient?

ELALDI N.

CCHF diagnostic and treatment by using human monoclonal antibodies, STOOCKHOLM, Sweden, 30 November - 01 December 2017

20. Discovery of Crimean‐Congo Hemorrhagic Fever Virus vaccine candidate antigens by protein microarray scanning and verification of the determined antigens by recombinant ELISA

GÜLÇE İZ S., DÖŞKAYA M., nakajima r., pablo j., Can H., Atalay Şahar E., et al.

2017 ISV Annual Congress, 5 - 07 October 2017, (Summary Text) Sustainable Development

21. Protein Mikroarray Tarama ile Kırım-Kongo Kanamalı Ate şi Virüsüneait a şı adayı antijenlerin ke şfi ve rekombinant ELISA ile do ğrulanması

GÜLÇE İZ S., DÖŞKAYA M., nakajima r., pablo j., jain a., Can H., et al.

20. Ulusal Parazitoloji Kongresi(Uluslararası Katılımlı), 25 - 29 September 2017, (Summary Text)

22. Yoğun Bakım Ünitesinde Gelişen KandidaEnfeksiyonlarının Değerlendirilmesi

BÜYÜKTUNA S. A., BAKIR M., ENGİN A., ELALDI N., ARSLAN G., BAKICI M. Z.

XVIII. TÜRK KLİNİK MİKROBİYOLOJİ VE İNFEKSİYON HASTALIKLARI KONGRESİ, Turkey, 22 - 26 March 2017, vol.1, pp.290-291, (Summary Text)

23. Knowledge attitudes and practice among healthcare workers at risk of acquiring Crimean Congo haemorrhagic fever

LEBLEBİCİOĞLU O. H., SÜNBÜL M., YILMAZ G., GÜNER H. R., Kanyılmaz D., ÖZKURT Z., et al.

26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Amsterdam, Netherlands, 9 - 12 April 2016, vol.1, pp.1-2

24. Yoğun Bakım Ünitesinde Gelişen Alet İlişkili İnfeksiyon Hızlarımız: INICC Sonuçları

ENGİN A., BÜYÜKTUNA S. A., ARSLAN G., ŞAHİN F., KOÇ S., GÜRSOY S., et al.

HİKON 2016, Turkey, 30 March - 03 April 2016, (Summary Text)

25. Kırım Kongo Kanamalı Ateş hastalarında serum karaciğer rejenerasyonunu artırıcı molekül Augmenter of Liver Regeneration Molecule ALR seviyesi ile hastalığın şiddeti ve viral yük düzeyinin ilişkisi

Gündag Ö., BAKIR M., ENGİN A., BÜYÜKTUNA S. A., GÖZEL M. G., BAKICI M. Z., et al.

Kurultay/ kongre, Turkey, 9 - 12 March 2016

26. Current Bacterial etiology and Antimicrobial Resistance in DFIS A Multicenter Proxpective Trial of TURK DAY

TURHAN V., UZUN G., hatipoğlu m., emel s., DEMİRASLAN H., emel e., et al.

20th Congress of Balkan Military Medical Committee “20 years of BMMC. Past, present, future”., Selanik, Greece, 8 - 11 June 2015, (Full Text)

27. Ufuktaki yeni antibiyotikler

ELALDI N.

5. Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Uzmanlık Derneği (EKMUD) Bilimsel Platformu, Antalya, Turkey, 1 April - 04 June 2015

28. Nozokomiyal Stenotrophomonas maltophilia bakteriyemi ve pnömoni gelişen hastaların demografik ve klinik özelliklerinin karşılaştırılması

GÖZEL M. G., ÇELİK C., ELALDI N., ENGİN A., BAKIR M.

HASTANE İNFEKSİYONLARI KONGRESİ, Turkey, 11 - 15 April 2014

29. Kırım Kongo kanamalı ateşi nde KKKA IFNA5 and IFNA10 gen polimorfizmleri ile hastalık prognozu ve mortalite ilişkisinin incelenmesi

YILMAZ M., ELALDI N., KÖKSAL B., YELKUVAN İ.

XIII. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Turkey, 27 - 30 October 2013, (Summary Text)

30. Kırım Kongo Kanamalı Ateşi nde KKKA İnterferon alfa IFN 5 ve IFN 10 Gen Polimorfizmlerinin Mortalite ve Hastalık Prognozu ile İlişkisinin İncelenmesi

YILMAZ M., ELALDI N., BAĞCI B., YELKOVAN İ.

XIII. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Turkey, 27 - 30 October 2013, (Summary Text)

31. Increasing antimicrobial resistance in nosocomial pathogens Multi drug resistant MDR and Pan drug resistant PDR Acinetobacter baumannii

ÇELİK C., GÖZEL M. G., DAYI F., BAKICI M. Z., ELALDI N.

23rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 27 - 30 April 2013

32. Tümör Nekroz Faktör Alfa 308G A TNF veİnterlökin 6 174G C IL 6 Gen Polimorfizmleri ile Kırım KongoKanamalı Ateşi Arasındaki İlişkinin Araştırılması

YILMAZ M., KÖKSAL B., ELALDI N., YELKUVAN İ.

21. Ulusal Biyoloji Kongresi Uluslararası katılımlı, Turkey, 3 - 07 September 2012, (Summary Text)

33. Tümör nekroz faktör alfa 308G A TNF ve interlökin 6 174G C IL 6 gen polimorfizmleri ile Kırım Kongo kanamalı ateşi arasındaki ilişkinin araştırılması

YILMAZ M., BAĞCI B., YELKOVAN İ., ELALDI N.

21.Ulusal Biyoloji Kongresi, Turkey, 3 - 07 September 2012, (Summary Text)

34. Efficacy of oral ribavirin treatment on serum viral loads and cytokine levels in severe Crimean Congo Hemorrhagic Fever CCHF cases

ELALDI N., KAYA Ş., GÜRSOY N., GÜNEŞ T., ENGİN A., KUBAR A., et al.

47th Interscience Congress on Antimicrobial Agents and Chemotherapy, 17 - 20 September 2007, (Summary Text)

35. Markedly Elevated Serum Cytokine Levels and High Viral Titers in Fatal Crimean Congo Hemorrhagic Fever CCHF

Elaldı N., Kaya Ş., Dökmetaş İ., Engin A., Gürsoy N., Kubar A., et al.

47th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Florida, United States Of America, 17 - 20 September 2007, (Full Text)

36. Markedly eleveted serum cytokine levels and high viral titers in fatal Crimean Congo Hemorrhagic Fever CCHF

ELALDI N., KAYA Ş., İLYAS D., ENGİN A., GÜRSOY N., KUBAR A., et al.

47th Interscience Conference on Antimicrobial Agents and Chemotherapy, 17 - 20 September 2007, (Summary Text)

37. Cutaneous anthrax in a teaching hospital, Turkey: a review of 39 cases

Engin A., Elaldi N., Dokmetas I., Bakici M., Bakir M.

17th European Congress of Clinical Microbiology and Infectious Diseases/25th International Congress of Chemotherapy, Munich, Germany, 31 March - 03 April 2007, vol.29, (Summary Text)

38. Comparison of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a historical cohort study in Turkey

Elaldi N., Bodur H., Celikbas A., Ozkurt Z., Leblebicioglu H., Bakir M., et al.

17th European Congress of Clinical Microbiology and Infectious Diseases/25th International Congress of Chemotherapy, Munich, Germany, 31 March - 03 April 2007, vol.29, (Summary Text)

39. Koroner Bypass Operasyonu Geçiren Hastalarda Preoperatif Statin Kullanılmasının Preoperatif Myokardial İskemi ve Reperfüzyon Hasarını önlemedeki katkısı

çetin h., MANDUZ Ş., berkan O., KATRANCIOĞLU N., TÜNEL H. A., ELALDI N., et al.

. 1-5 Eylül 2004 Dedeman, Turkey, 1 - 05 September 2004

40. İnfektif Endokardit Cerrahi Tedavisinde Klinik Uygulamalarımız

MANDUZ Ş., berkan O., KATRANCIOĞLU N., TÜNEL H. A., çetin h., ELALDI N., et al.

1-5 Eylül 2004 Dedeman-Kapadokya., Turkey, 1 - 05 September 2004

41. Is inracardiac trombus a risk factor for the development of pulmonary artery aneurysm in behcet disease?

GÖNLÜGÜR U., ATALAR M. H., kaptanoğlu M., MANDUZ Ş., NADİR A., Akkurt İ., et al.

European Respıratory Journal, 12th ERS Annual Congress Stockholm, Sweden, 14 - 18 September 2002

42. Hemodiyaliz Hastaları ve Santral Venöz Bağlantılı Enfeksiyonlar

ELALDI N., BAKIR M., DÖKMETAŞ İ., MANDUZ Ş., ALAGÖZLÜ H., CANDAN F., et al.

9. Türk Klinik mikrobiyoloji Ve Enfeksiyon Hastalıları Kongresi, Turkey, 3 - 08 October 1999

Books 2

1. Kırım-Kongo Kanamalı Ateşi

ELALDI N.

in: Cumhuriyet Tıp Günleri - Güncel Pratik Tıp El Kitabı-2, Hilmi Ataseven, Ahmet Altun, Editor, Sivas Cumhuriyet Üniversitesi Yayınevi, Sivas, pp.121-127, 2021

2. Topikal antimikrobiyaller

ELALDI N.

in: Enfeksiyon Hastalıkları ve Mikrobiyolojisi, Topçu Ayşe Willke, Söyletir Güner, Doğanay Mehmet, Editor, Nobel Tıp Kitabevleri, İstanbul,, İstanbul, pp.359-363, 2017

Metrics